Amer Bio Medica Stock Cash And Equivalents
| ABMCDelisted Stock | USD 0.01 0 38.00% |
Amer Bio Medica fundamentals help investors to digest information that contributes to Amer Bio's financial success or failures. It also enables traders to predict the movement of Amer Pink Sheet. The fundamental analysis module provides a way to measure Amer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amer Bio pink sheet.
Amer |
Amer Bio Medica Company Cash And Equivalents Analysis
Amer Bio's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Amer Bio Cash And Equivalents | 2 K |
Most of Amer Bio's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amer Bio Medica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Amer Bio Medica has 2 K in Cash And Equivalents. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
Amer Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amer Bio's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amer Bio could also be used in its relative valuation, which is a method of valuing Amer Bio by comparing valuation metrics of similar companies.Amer Bio is currently under evaluation in cash and equivalents category among its peers.
Amer Fundamentals
| Return On Asset | -0.42 | ||||
| Profit Margin | (1.13) % | ||||
| Operating Margin | (0.93) % | ||||
| Current Valuation | 2.09 M | ||||
| Shares Outstanding | 48.1 M | ||||
| Shares Owned By Insiders | 31.26 % | ||||
| Number Of Shares Shorted | 5.13 K | ||||
| Price To Earning | (6.72) X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 2.22 M | ||||
| Gross Profit | 548 K | ||||
| EBITDA | (199 K) | ||||
| Net Income | (463 K) | ||||
| Cash And Equivalents | 2 K | ||||
| Total Debt | 1.53 M | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 0.25 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | (673 K) | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Number Of Employees | 32 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 480.99 K | ||||
| Total Asset | 1.88 M | ||||
| Retained Earnings | (21.24 M) | ||||
| Working Capital | 937 K | ||||
| Current Asset | 2.56 M | ||||
| Current Liabilities | 1.62 M | ||||
| Z Score | -14.4 | ||||
| Net Asset | 1.88 M |
About Amer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amer Bio Medica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amer Bio Medica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |